Pharmacokinetics Study in Patients With Impaired Hepatic Function

Clinical trial NCT02586194 · COMPLETED

Trial details

NCT number: NCT02586194
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Impaired Hepatic Function

Start date: 2015-12-28
Primary completion: 2016-09-27
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.